CHU Strasbourg-Hautepierre

Strasbourg, Alsace 67098

2 studies enrolling now · 3 studies all time

What they study most

Refractory Autoimmune Diseases, Rheumatoid Arthritis, Urothelial Cancer

Studies at this site

• Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease Progression on or After Immunotherapy — Recruiting now
• A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases — Recruiting now
• A Study of Baricitinib (LY3009104) in Participants With Rheumatoid Arthritis — Completed